Why current SaaS models need to be disrupted to meet changing needs and realities

Commercial SaaS has become a fixed cost regardless of outcome

The previous evolution of rep-enablement software in healthcare was driven by new devices, integrated solutions, and the promise of cost savings through the software-as-a-service (SaaS) model that never materialized. Almost 10 years later, this approach to rep enablement has reached its limits in terms of utilization, effectiveness for modern rep roles, and driving further cost savings.


Recent advances in technology have the potential to reduce or eliminate device and integration barriers for most pharmaceutical sales and marketing teams, and new advances in pharma-specific rep enablement software have introduced efficiency through result-based SaaS pricing and tailored applications that maximize utilization that allows reps to activate their HCPs in new ways.

Download the free paper to analyze how you can fully maximize your field force’s impact through modern technologies

About Indegene


Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations, and medical expertise and drive better health and business outcomes. Indegene’s IP-based solutions help clients drive revenues and productivity by making transformational leaps in digitalization of customer engagement, health reform, healthcare cost reduction, and health outcomes improvement.

Contact Information

Indegene Omnipresence, Inc

600 Third Avenue, 2nd Floor, New York, NEW YORK, 10016


Useful Links


> Request a demo


> About us

> News 

> Resources

© Indegene  |  About Indegene  | Privacy Policy

Join the Conversation